ICON Web & News
Virtual Journal
Everything
Resources
Virtual Journal
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Ratings Comment
Guidelines
Links
Quick Search:
Keywords:
Search:
Search Using OECD Database
Details
Return to Previous Page
Addition or Correction
Title:
Effect of Particle Size of Hydroxyapatite Nanoparticles on its Biocompatibility
Date:
12/2012
Link to Journal Abstract
Abstract:
Nano-particulate biomaterials have been used in clinical diagnosis and treatment, as drug carrier or in cosmetics because of their excellent performance properties. The toxicity and biocompatibility of nanoparticles (NPs), however, are always a focused concern for a doctor or a scientist. At present, there is almost no systemic evaluation standard or testing methods of safety for nanoparticles. In this study, two kinds of hydroxylapatite, (HAP) NPs with different particle sizes were selected. A number of biocompatibility tests in vivo or in vitro were conducted. They were cytotoxicity (MTT assay), genotoxicity (Ames, Mouse Lymphoma Mutagenesis Assay), and systemic toxicity (Acute and Subacute). The results indicated that, under the concentration of 100 mg/L, both HAP NPs could cause significant inhibition of cell growth. The size of NPs might have close tie with cell response. The mutagenic test in vitro was negative in this study. Histopathological findings showed that both kinds of HAP NPs could induce pseudotubercles in lung. Moreover, smaller size of nanoparticles resulted in a vacuolar degeneration of nephric tubule epithelium at 7 days post-intraveneous injection. The results implied that the size of NPs might play an important role in the biocompatibility of the materials. The kidney might be the main organ of discharge of nanoparticles from body.
Non-technical Summary:
In this study, two kinds of hydroxylapatite, (HAP) NPs with different particle sizes were selected. A number of biocompatibility tests in vivo or in vitro were conducted. They were cytotoxicity (MTT assay), genotoxicity (Ames, Mouse Lymphoma Mutagenesis Assay), and systemic toxicity (Acute and Subacute).
Content Emphasis
Peer Reviewed Journal Article
Exposure Or Hazard Target
Mammalian
Exposure Pathway
Other/Unspecified
Method Of Study
Multiple
Paper Type
Hazard
Particle Type
Organic/Polymers
Production Method
Engineered
Risk Exposure Group
General Population
Target Audience
Technical Research
Citation:
IEEE Transactions on Nanobioscience, 11(4): 336-340 (December 2012)
Publication:
IEEE Transactions on Nanobioscience
Author:
Ding T, Xue Y, Lu H, Huang Z, Sun J
Volume:
11
Number:
4
Pages:
336-340
Last updated on December 12, 2012
Permalink
Join Us
|
About
|
Newsroom
|
Working Groups
|
Projects
|
Resources
|
Virtual Journal
|
Events
|
Logout
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Background
Organization
Sponsors
Participants
Contact Us
ICON Releases
News
Media Alert
RSS
Governance
Knowledge Base
Best Practices
Communications
Virtual Journal
Analyze Database
Good Nano Guide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Links
Council Events
Other Events
Virtual Journal
Analyze Database
The GoodNanoGuide
Nano EHS Research Needs
Current Practices Survey